XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Operating expenses        
Research and development $ 2,611,948 $ 1,467,736 $ 4,063,184 $ 1,938,712
General and administrative 4,674,121 2,674,920 7,287,214 4,078,385
Total operating expenses 7,286,069 4,142,656 11,350,398 6,017,097
Operating loss (7,286,069) (4,142,656) (11,350,398) (6,017,097)
Other income 23,540 79 14,562 138
Loss before income taxes (7,262,529) (4,142,577) (11,335,836) (6,016,959)
Income taxes
Net loss (7,262,529) (4,142,577) (11,335,836) (6,016,959)
Deemed dividend attributable to preferred stock (11,479,308) (11,479,308)
Net loss applicable to common shareholders $ (7,262,529) $ (15,621,885) $ (11,335,836) $ (17,496,267)
Net loss per share of common stock, basic and diluted: (in dollars per share) $ (0.80) $ (5.08) $ (1.44) $ (6.11)
Weighted average shares outstanding - basic and diluted (in shares) 9,126,153 3,073,803 7,852,907 2,864,033